Yulia Slavina

Bitrue lists SNPS/USDT and MCAT/USDT perpetual futures pairs

Bitrue lists SNPS/USDT and MCAT/USDT perpetual futures pairs
Bitrue adds new perpetual futures pairs

Bitrue announced the listing of two new USDT-based perpetual futures trading pairs, SNPS/USDT (Synopsys) and MCAT/USDT (MarsCat), which will go live at 12:00 UTC on October 13, 2026, with specified contract details available on their support page.

Leading Crypto Broker in United States
8.5/10
*Rated by real traders on Traders Union
  • Chosen by 1 600+ local traders in the last 3 months.
  • Traders earn on average 12% more per month vs other brokers.
Start with Coinbase

Bitrue has announced that it will launch two new USDT-based perpetual futures trading pairs, SNPS/USDT (tracking Synopsys) and MCAT/USDT (tracking MarsCat), with trading scheduled to begin at 12:00 UTC on October 13, 2026. According to the official release, contract specifications vary by asset, including different tick sizes (2 for SNPS/USDT and 5 for MCAT/USDT) and maximum leverage (20× for SNPS/USDT and 10× for MCAT/USDT), with further details such as funding rates and margin requirements available on Bitrue’s live futures trading page.

Bitrue is a cryptocurrency exchange operated by Innovations Technologies Limitada, with a global presence including offices in the USA, Europe, and Asia-Pacific. The platform provides access to over 160 cryptocurrency trading pairs, including major coins such as Bitcoin, Ethereum, Tether, and Ripple, and supports features like copy trading, cold wallet storage for client funds, multi-level security with two-factor authentication, and TradingView chart integration. More details can be found in the broker profile on Traders Union.

For additional background, our earlier news about Bitrue detailed the launch of a 21-day fixed-term staking option for HYPE, BTC, and NEAR through its Earn service; you can read more in the previous Bitrue update on Traders Union.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.